US › Healthcare

GeoVax Labs Inc (GOVX)

US · Healthcare · Biotechnology

$0.24-7.56%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

Revenue YoY

-100.0%

Net profit

$-4.4M

EPS

$-0.97

EPS estimate

$-2.16

EPS came in at -0.97 against a street estimate of -2.16 — a beat of 55.1%.

Key statistics

Market cap

$2.7M

Forward P/E

9.7

P/B

25.75

Book value

$0.24

EPS (TTM)

$-8.84

52-week high

$15.75

52-week low

$0.24

50-day MA

$0.52

200-day MA

$1.55

Beta

3.69

Analyst view

Analysts rate GeoVax Labs Inc a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $10.00.

Shareholding

Insiders

0.03%

Institutions

9.77%

Largest institutional holders

Fund	Stake
Jane Street Group LLC	8.59%
HRT FINANCIAL LLC	3.45%
Geode Capital Management, LLC	0.57%
TWO SIGMA SECURITIES, LLC	0.29%
Vanguard Fiduciary Trust Co	0.14%
Tower Research Capital LLC	0.10%
Vanguard Capital Management, LLC	0.09%
SBI Securities Co Ltd	0.07%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for GeoVax Labs Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.